Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$201,787
in 1 filing

Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Nofi Michael −$202K Chief Financial Officer sold 41% of stake
Date Insider Transaction Shares Price Value Owned after
2026-10-01 Fox Jonathan C Director Grant or award +308 25,141
2026-07-01 Fox Jonathan C Director Grant or award +319 24,833
2026-06-05 Fox Jonathan C Director Grant or award · Stock Option (Right to Buy) +16,377 16,377
2026-04-01 Fox Jonathan C Director Grant or award +339 24,514
2026-01-02 Fox Jonathan C Director Grant or award +473 24,175
2025-11-11 Fox Jonathan C Director Purchase +10,700 $18.64 $199K 23,702
2025-10-01 Fox Jonathan C Director Grant or award +728 13,002
2025-07-01 Fox Jonathan C Director Grant or award +858 12,274
2025-06-16 Fox Jonathan C Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2025-04-01 Fox Jonathan C Director Grant or award +559 11,416
2024-06-10 Fox Jonathan C Director Grant or award · Stock Option (Right to Buy) +20,594 20,594
2023-12-26 Fox Jonathan C Director Purchase +10,857 $9.30 $101K 10,857
2023-06-12 Fox Jonathan C Director Grant or award · Stock Option (Right to Buy) +22,123 22,123
2023-03-03 Fox Jonathan C Director Grant or award · Stock Option (Right to Buy) +43,731 43,731

Page 1 of 1 · 14 trades